Viewing Study NCT04296825



Ignite Creation Date: 2024-05-06 @ 2:22 PM
Last Modification Date: 2024-10-26 @ 1:29 PM
Study NCT ID: NCT04296825
Status: COMPLETED
Last Update Posted: 2020-03-05
First Post: 2020-03-02

Brief Title: Effect of Camel Milk With Probiotic on Type 2 Diabetes Mellitus
Sponsor: China Agricultural University
Organization: China Agricultural University

Study Overview

Official Title: Effect of Camel Milk Containing Bifidobacterium Animalis A6 on Chinese People With Type 2 Diabetes Mellitus
Status: COMPLETED
Status Verified Date: 2018-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to investigate the effects of dietary supplement with Camel Milk containing Bifidobacterium animalis A6 on the plasma glucose and other related cytokines in patients with type 2 diabetes mellitus 45 patients with type 2 diabetes mellitus were recruited and a Double Blind Randomized Parallel Controlled Trial was performed The fasting glycaemia 2 hour postprandial glycaemia insulin uric acid and serum lipid total cholesterol total triglyceride high-density lipoprotein cholesterol and low-density lipoprotein cholesterol were measured as Primary Outcome The Fecal microbiome fecal metabolites gut hormones amylin ghrelin glucagon-like peptide 1 pancreatic polypeptide inflammation cytokines TNF-α IL-6 MCP-1 myokines FGF-21 irisin osteocrinmusclin osteonectin and adipokines adiponectin resistin lipocalin-2 adipsin and body composition analysis were also assessed
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None